HIV/AIDS
Conditions
Interventions
Sponsors
College of Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: All HIV-positive pregnant women who attend antenatal clinics in the selected study health centers and babies born to them.
Exclusion criteria
Exclusion criteria: 1. Those who not permanent residents of catchment villages surrounding the health facilities and who plan to move out of the catchment villages in the following 6-9 months. 2. Those who at the time of enrollment intend to relocate to other districts, 3. Those who cannot independently give informed consent because of immediate life¿threatening illness or mental disorders. 4. Those who did not receive ANC care, including the initial visit, at the randomized health centers or received their first HIV test in the postnatal period. This is to make sure that we are assessing retention of the mother¿infant pairs from the first point of entry into the PMTCT cascade.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of HIV-exposed infants retained in HIV care and treatment at 12 months postpartum;Proportion of HIV-positive women retained in care and treatment (Option B+ regimen) at 12 months postpartum. | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of HIV-exposed infants who have received HIV DNA PCR test by 2 months of age and received results;Proportion of HIV exposed infants receiving all cotrimoxazole refills from 6 weeks to 6 months of age;Mean number of scheduled visits made by mother and infant from first ANC visit to 12 months postpartum.;Proportion of HIV-exposed infants retained in care and treatment at 24 months postpartum.;Proportion of women alive and on Option B+ ART regimen at 24 months postpartum;Cost per Mother Infant Pair (MIP) retained at 12 months of age;Cost per early infant diagnosis test (HIV DNA PCR) result received.;Cost per infant initiated on ART | — |
Countries
Malawi
Contacts
Public ContactEmily Churchman-Kobayashi
Senior Programs Manager
Outcome results
None listed